2021
DOI: 10.1542/peds.2021-054272
|View full text |Cite
|
Sign up to set email alerts
|

Promoting Human Milk and Breastfeeding for the Very Low Birth Weight Infant

Abstract: The guidance in this report does not indicate an exclusive course of treatment or serve as a standard of medical care. Variations, taking into account individual circumstances, may be appropriate.All clinical reports from the American Academy of Pediatrics automatically expire 5 years after publication unless reaffirmed, revised, or retired at or before that time.

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
4
1

Citation Types

4
92
0
3

Year Published

2021
2021
2024
2024

Publication Types

Select...
10

Relationship

0
10

Authors

Journals

citations
Cited by 133 publications
(99 citation statements)
references
References 131 publications
4
92
0
3
Order By: Relevance
“…As one of the human milk bioactive components, hMEVs are expected to be safe for oral consumption, and without toxicity, supporting its use as a nutraceutical/therapeutic agent. Perhaps one potential use of isolated hMEVs would be human milk fortification [ 206 , 207 ] to enhance the beneficial effects of maternal breastmilk or donor milk or to improve infant formula. For preterm infants, especially whose with very low birth weight, this could help reduce their high risk of morbidity and mortality [ 207 , 208 ].…”
Section: Challenges and Clinical Implicationsmentioning
confidence: 99%
“…As one of the human milk bioactive components, hMEVs are expected to be safe for oral consumption, and without toxicity, supporting its use as a nutraceutical/therapeutic agent. Perhaps one potential use of isolated hMEVs would be human milk fortification [ 206 , 207 ] to enhance the beneficial effects of maternal breastmilk or donor milk or to improve infant formula. For preterm infants, especially whose with very low birth weight, this could help reduce their high risk of morbidity and mortality [ 207 , 208 ].…”
Section: Challenges and Clinical Implicationsmentioning
confidence: 99%
“…Very preterm infants born before 32 weeks’ gestation are vulnerable to both undernutrition and impaired neurodevelopment [ 6 , 7 ]. The current standard of nutritional care for these infants is a human milk diet, based on the established health benefits of human milk, with fortification added to meet this population’s high nutrient needs [ 8 ]. Standard fortification—adding a fixed quantity of multicomponent fortifier based on average reference values for macronutrient content—is practiced routinely, but this strategy does not achieve target nutrient intakes for all infants [ 9 ].…”
Section: Introductionmentioning
confidence: 99%
“…MOM can provide newborns with energy, the nutrients required for growth, essential microbes, and other beneficial bioactive components, such as HM oligosaccharides and immunoglobulins (2). It can also reduce short-term complications, such as neonatal necrotizing enterocolitis (NEC), chronic lung diseases, retinopathy of prematurity, late-onset sepsis, and more significantly, it promotes neurodevelopment in the long term (3)(4)(5). Donor milk (DM) is recommended by many international agencies, such as the World Health Organization, to feed vulnerable infants as the suboptimal option when MOM is not available (6).…”
Section: Introductionmentioning
confidence: 99%